Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MACROGENICS INCMGNX · Entity 6104 | Sr VP, Research & CSO | October 06, 2026 | October 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MACROGENICS INC
Report date October 06, 2026 · Filed October 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 193,799 |
Reported balance
After 2026-10-06 transaction · row 1
1 source rowRow 1 · 2026-10-06 · Exercise / conversion · Acquired 8,000 · Balance 193,799 F1: The transaction represents an exercise and hold of options. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.60 · Expires 2035-02-07 | Direct | 80,000 |
Reported balance
After 2026-10-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-10-06 · Exercise / conversion · Disposed 8,000 · Balance 80,000 F2: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction represents an exercise and hold of options.
F2: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2021 Filed May 18, 2021 21:06 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionRestricted Stock Unit · Derivative | 5,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001125345-21-000084 · wf-form4_162137192693194.xml · derivative · entry 3 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On May 14, 2020, the reporting person was granted 10,000 restricted stock units, 50% of which vested on May 14, 2021 and 50% of which will vest on May 14, 2022, subject to the reporting person's continued employment with the Company. Restricted stock units convert into the Company's common stock on a one-for-one basis. F1 · derivative.exercise_date: On May 14, 2020, the reporting person was granted 10,000 restricted stock units, 50% of which vested on May 14, 2021 and 50% of which will vest on May 14, 2022, subject to the reporting person's continued employment with the Company. Restricted stock units convert into the Company's common stock on a one-for-one basis. F1 · derivative.expiration_date: On May 14, 2020, the reporting person was granted 10,000 restricted stock units, 50% of which vested on May 14, 2021 and 50% of which will vest on May 14, 2022, subject to the reporting person's continued employment with the Company. Restricted stock units convert into the Company's common stock on a one-for-one basis. Read SEC document |
| May 14, 2021 Filed May 18, 2021 21:06 UTC | MACROGENICS INC MGNX · Entity 6104 | Tax withholdingCommon Stock | 2,416 | $29.49 | $71,247.84 |
DisclosureSEC source: 0001125345-21-000084 · wf-form4_162137192693194.xml · nonDerivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,474 Read SEC document |
| May 14, 2021 Filed May 18, 2021 21:06 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001125345-21-000084 · wf-form4_162137192693194.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On May 14, 2020, the reporting person was granted 10,000 restricted stock units, 50% of which vested on May 14, 2021 and 50% of which will vest on May 14, 2022, subject to the reporting person's continued employment with the Company. Restricted stock units convert into the Company's common stock on a one-for-one basis. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 21:04 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 3,917 | $32.00 | $125,344.00 |
DisclosureSEC source: 0001125345-21-000040 · wf-form4_161661982603129.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,890 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 23:00 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee stock option (right to buy) · Derivative | 120,000 | $0.00 Strike: $19.18 | $0.00 |
DisclosureSEC source: 0001125345-21-000022 · wf-form4_161420761691539.xml · derivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2031-02-22 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| September 18, 2020 Filed Sep 21, 2020 20:51 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 18,339 | $32.00 | $586,848.00 |
DisclosureSEC source: 0001125345-20-000136 · wf-form4_160072147240711.xml · nonDerivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,807 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $32.00 to $32.01. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 20:51 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 44,512 | $29.88 | $1,330,018.56 |
DisclosureSEC source: 0001125345-20-000136 · wf-form4_160072147240711.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,146 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $28.59 to $31.35. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 14, 2020 Filed May 19, 2020 01:21 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantRestricted Stock Unit · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001125345-20-000096 · wf-form4_158985129585734.xml · derivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs will vest as to 50% of the total shares on May 14, 2021 and 50% on May 14, 2022, subject to the reporting person's continued employment with the Company. F2 · derivative.expiration_date: The RSUs will vest as to 50% of the total shares on May 14, 2021 and 50% on May 14, 2022, subject to the reporting person's continued employment with the Company. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:47 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee stock option (right to buy) · Derivative | 100,000 | $11.50 Strike: $11.50 | $1,150,000.00 |
DisclosureSEC source: 0001125345-20-000027 · wf-form4_158258084014609.xml · derivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-02-20 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 21:01 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee stock option (right to buy) · Derivative | 90,000 | $0.00 Strike: $21.88 | $0.00 |
DisclosureSEC source: 0001125345-19-000029 · wf-form4_155112847071551.xml · derivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2029-02-21 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 22:24 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee stock option (right to buy) · Derivative | 70,000 | $0.00 Strike: $28.94 | $0.00 |
DisclosureSEC source: 0001125345-18-000045 · wf-form4_152037505793642.xml · derivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2028-03-02 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 20:47 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 26,632 | $0.94 Strike: $0.94 | $25,034.08 |
DisclosureSEC source: 0001125345-17-000085 · wf-form4_150118845634227.xml · derivative · entry 4 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,632 shares Expires 2022-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 20:47 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 26,632 | $1.51 Strike: $1.51 | $40,214.32 |
DisclosureSEC source: 0001125345-17-000085 · wf-form4_150118845634227.xml · derivative · entry 3 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,632 shares Expires 2023-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 20:47 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 26,632 | $0.94 | $25,034.08 |
DisclosureSEC source: 0001125345-17-000085 · wf-form4_150118845634227.xml · nonDerivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2017 Filed Jul 27, 2017 20:47 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 26,632 | $1.51 | $40,214.32 |
DisclosureSEC source: 0001125345-17-000085 · wf-form4_150118845634227.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 22:45 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantCommon Stock · Derivative | 67,500 | $20.53 Strike: $20.53 | $1,385,775.00 |
DisclosureSEC source: 0001125345-17-000031 · wf-form4_148728509153055.xml · derivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,500 Underlying: Common Stock · 67,500 shares Expires 2027-02-15 F1 · derivative.exercise_date: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. Read SEC document |
| October 19, 2016 Filed Oct 21, 2016 23:19 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,349 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001552781-16-002007 · e00547_bonvini-form4.xml · derivative · entry 5 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,349 shares Expires 2020-01-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 19, 2016 Filed Oct 21, 2016 23:19 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 5,349 | $0.94 | $5,028.06 |
DisclosureSEC source: 0001552781-16-002007 · e00547_bonvini-form4.xml · nonDerivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 19, 2016 Filed Feb 8, 2017 22:18 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 5,349 | $0.94 | $5,028.06 |
DisclosureSEC source: 0001125345-17-000018 · wf-form5_148659228598967.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Due to clerical error, the reported amount of securities beneficially owned after the transaction on 10/19/16 and reported on a Form 4 on 10/21/16, was incorrect. The corrected amount now includes the disposal of 7550 shares which occurred on 9/22/15 and was reported on Form 5 on 2/12/16. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 22:10 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $28.94 | $0.00 |
DisclosureSEC source: 0001552781-16-001950 · e00506_bonvini-form4.xml · derivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2026-09-14 F1 · derivative.exercise_date: 12.5% of the option becomes exercisable on March 14, 2017 and the remaining 87.5% vests in 14 substantially equal quarterly installments thereafter. Read SEC document |
| February 11, 2016 Filed Oct 21, 2016 23:19 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,309 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001552781-16-002007 · e00547_bonvini-form4.xml · derivative · entry 4 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,349 Underlying: Common Stock · 1,309 shares Expires 2020-01-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction occurred on February 11, 2016. Due to an administrative error, the reporting person failed to timely file a Form 4 to report this transaction. Read SEC document |
| February 11, 2016 Filed Oct 21, 2016 23:19 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,653 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001552781-16-002007 · e00547_bonvini-form4.xml · derivative · entry 3 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,653 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction occurred on February 11, 2016. Due to an administrative error, the reporting person failed to timely file a Form 4 to report this transaction. Read SEC document |
| February 11, 2016 Filed Oct 21, 2016 23:19 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 11,962 | $0.94 | $11,244.28 |
DisclosureSEC source: 0001552781-16-002007 · e00547_bonvini-form4.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction occurred on February 11, 2016. Due to an administrative error, the reporting person failed to timely file a Form 4 to report this transaction. Read SEC document |
| September 22, 2015 Filed Feb 8, 2017 22:18 UTC | MACROGENICS INC MGNX · Entity 6104 | OtherCommon Stock | 7,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001125345-17-000018 · wf-form5_148659228598967.xml · nonDerivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 7,550 F2 · balance_after: The 7550 shares disposed of on 9/22/15 were transferred to the Bonvini Family Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.